Commit To Buy Avalanche Biotechnologies At $5, Earn 20.3% Annualized Using Options
January 26, 2016 at 11:55 AM EST
Investors eyeing a purchase of Avalanche Biotechnologies, Inc. (AAVL) shares, but cautious about paying the going market price of $6.20/share, might benefit from considering selling puts among the alternative strategies at their disposal..